OUR LOCATIONS
THE JOURNEY FROM UNMET NEED TO LIFE-CHANGING MEDICINE
A breakthrough isn't a light bulb going off over some eccentric genius's head. It's a total team effort that demands passion, perseverance and bold innovation every step of the way. Visionaries, strategists, scientists, researchers, technologists, manufacturing and testing specialists — we all work as one to turn inspirations into tangible, transformative solutions. Want to know more?
IT STARTS WITH STRATEGIC VISION
Our U.S. Corporate Headquarters in Nutley, NJ, is the nerve center of a fully integrated pharmaceutical business focused on neurology and oncology. Here, we identify major medical challenges that Eisai is uniquely capable of tackling, set priorities, marshal resources and incite innovation.
The JOURNEY LEADS TO THE FRONTIERS OF R&D
At the Eisai Center for Genetics Guided Dementia Discovery (G2D2) in Cambridge, MA, some of the best minds in human genetics, data sciences and precision chemistry collaborate to accelerate discovery of breakthrough immunodementia precision therapeutics.
IT ISN'T A BREAKTHROUGH UNTIL PATIENTS ACTUALLY BENEFIT
Manufacturing, testing and distribution are just as vital to Eisai Innovation as R&D. We never let up, because we never forget that the real goal is to improve the lives of our patients, their caregivers and loved ones.
THE PRIMARY FOCUS OF HEALTH CARE MUST ALWAYS BE THE PATIENT, THE PATIENT’S FAMILY AND, FROM A GENERAL VANTAGE POINT, THE PUBLIC AS A WHOLE. THESE ARE THE PEOPLE WE MUST SERVE.
OUR EXTON CAMPUS
At this vibrant innovation hub, we develop, manufacture and test biologics targeting cancers or neurodegenerative diseases.
A wide-variety of biologic therapeutic, research and development within Deep Human Biology Learning (DHBL) is conducted within the 60,000-square-foot Exton Research Building, including antibody generation and engineering, analytical and process development, chemistry, manufacturing and controls (CMC) program management, analytical outsourcing, Development Quality Assurance (DQA), Product Quality (PQ) and site support functions (IT, Facilities, HR, Training).
Our 60,000-square-foot Biologics Pilot Plant manufactures and tests biologic drug substances, which are created from living organisms, and are used in preclinical and clinical studies. This LEED-certified plant includes 2000L and 1000L bioreactors. It is currently being updated to support the commercialization of novel biological products.
The 216 Warehouse Building is our-state-of-the-art storage facility for a wide range of materials and equipment used in studies, manufacturing and R&D.
ADDITIONAL MANUFACTURING AND LOGISTICS CENTERS
Our Baltimore, MD, plant exemplifies our determination to address patients’ unmet needs. This plant ensures that patients worldwide will have access to a special implant used to treat a rare form of brain cancer.
The specialists at our Raleigh, NC, facility direct our global logistics and supervise external manufacturers. Though we believe in making our own medicines, we won’t hesitate to outsource if it can improve the end product. That’s part of putting patients first.
EXPLORE OUR GLOBAL LOCATIONS
Eisai Co., Ltd., a leading global R&D pharmaceutical company, is located in Tokyo.
VISIT EISAI JAPAN
Eisai Limited is the Canadian pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd.
VISIT EISAI CANADA
Eisai EMEA is the European hub of Eisai Co., Ltd. for Europe, the Middle East and Africa.
VISIT EISAI EUROPE